ArticleJournal of cardiovascular electrophysiology2026
Terminal S Wave Pattern in Lead V3 as a Simple Marker for Ventricular Tachycardia Risk Stratification in Patients With Repaired Tetralogy of Fallot.
Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionPatients with repaired tetralogy of Fallot (rTOF) remain at risk of ventricular tachycardia (VT). This risk is most commonly related to slow conduction within the septal isthmus, which is defined as the region between the ventricular septal defect (VSD) patch and adjacent valvular annuli. While assessment of septal isthmus conduction currently requires invasive electrophysiological mapping, the 12-lead electrocardiogram (ECG) may offer a noninvasive alternative. Therefore, the present study aimed to identify ECG markers reflecting septal isthmus conduction properties and evaluate their ability to predict isthmus conduction characteristics and VT inducibility. METHODS AND
resultsIn five patients with rTOF undergoing septal isthmus ablation, 12-lead ECGs obtained before and after ablation were compared to identify candidate ECG markers. The identified marker was validated in an independent cohort of 23 patients stratified according to septal isthmus conduction properties into normal conduction (Normal, n = 5), slow-conducting isthmus (SCI, n = 10), and conduction block (Block, n = 8) groups. The results indicated that the terminal S wave (TSW) in lead V3 became more prominent after ablation compared with that before ablation. In the validation cohort, V3 TSW was categorized as absent, small (< 0.1 mV), or large (≥ 0.1 mV), and the TSW patterns differed significantly among the groups (p < 0.001). Specifically, absent TSW was dominant in the Normal group (4/5, 80%), small TSW was the most frequent in the SCI group (7/10, 70%), and large TSW was predominant in the Block group (7/8, 87.5%). Small TSW predicted SCI with 70% sensitivity and 85% specificity (p = 0.013), whereas large TSW predicted Block with 88% sensitivity and 80% specificity (p = 0.006). Moreover, large TSW predicted VT non-inducibility with high specificity and high positive predictive value (p = 0.019).
conclusionThis study indicates that V3 TSW is a simple, noninvasive ECG marker reflecting septal isthmus conduction properties in rTOF, suggesting its potential utility for VT risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.